SAN DIEGO – How effectively a sponsor, CRO or site responds to a trial-disrupting emergency all depends on the planning they do long before disaster strikes.
Don’t wait to prepare, Jennifer Sheller, Merck’s North American regional head of global clinical trial operations, advised attendees at the Drug Information Association conference last week.